The firm's overall revenue rose 8 percent, driven by growth in established pharmaceuticals and medical devices.
Pathologists at academic medical centers are using intentional change-management strategies to overcome some intangible barriers digital uptake.
The deal will help CHOP to expand the reach of its diagnostic innovations, allow Labcorp to grow its offerings, and enable the parties to combine resources to accelerate test development.
With the mark, the system, a fully automated blood culture platform meant for diagnosing bloodstream infections, can be sold throughout the EU.
NEW YORK – Roche on Monday announced that it has received CE marking for a blood test to detect neuroinflammation in patients with multiple sclerosis. The Elecsys Neurofilament Light Chain test ...
NEW YORK – Laboratory Corporation of America and Children's Hospital of Philadelphia (CHOP) on Monday announced a strategic collaboration to accelerate the development of and access to specialized ...
NEW YORK – What were the articles that gained the most interest from 360Dx readers last week? Here are the top five: ...
The test, which leverages technology that mimics a dog's ability to sense disease in humans, analyzes cancer-associated volatile organic compounds found in urine samples.
The assay measures three host-immune proteins to indicate the likelihood of bacterial or viral infections, and is validated for use on Beckman Coulter immunoassay analyzers.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results